Fully Detargeted Polyethylene Glycol-coated Adenovirus Vectors Are Potent Genetic Vaccines and Escape from Pre-existing Anti-adenovirus Antibodies
Open Access
- 1 January 2008
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (1) , 154-162
- https://doi.org/10.1038/sj.mt.6300306
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus VectorsJournal of Virology, 2007
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006
- Alteration of epitope recognition pattern in Ag85B and ESAT‐6 has a profound influence on vaccine‐induced protection against Mycobacterium tuberculosisEuropean Journal of Immunology, 2006
- Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cellsGene Therapy, 2005
- Adenovirus Binding to Blood Factors Results in Liver Cell Infection and HepatotoxicityJournal of Virology, 2005
- PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profileGene Therapy, 2005
- Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus ImmunityJournal of Virology, 2003
- Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag GeneJournal of Virology, 2003
- Efficient Transformation of Primary Human Amniocytes by E1 Functions of Ad5: Generation of New Cell Lines for Adenoviral Vector ProductionHuman Gene Therapy, 2000
- The liver as a site of T-cell apoptosis: graveyard, or killing field?Immunological Reviews, 2000